Antisense oligonucleotide treatments for psoriasis

By White PJ   Atley LM   Wraight CJ  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 1, 2004-01 ,pp. : 75-81

Informa Healthcare

Access to resources Recommend Favorite

RNase H-Independent Antisense Activity of Oligonucleotide N3′→P5′ Phosphoramidates

By Heidenreich Olaf   Nerenberg Michael  

Nucleic Acids Research, Vol. 25, Iss. 4, 1997-01 ,pp. : 776-780

Oxford University Press

Access to resources Recommend Favorite

Oligonucleotide–europium complex conjugate designed to cleave the 5′ cap structure of the ICAM‐1 transcript potentiates antisense activity in cells

By Baker Brenda F.   Lot Sidney S.   Kringel Jim   Cheng‐Flournoy Shin   Villiet Pierre   Sasmor Henri M.   Siwkowski Andrew M.   Chappell Lara L.   Morrow Janet R.  

Nucleic Acids Research, Vol. 27, Iss. 6, 1999-03 ,pp. : 1547-1551

Oxford University Press

Access to resources Recommend Favorite

Oligonucleotide Labeling Using BODIPY Phosphoramidite

By Tram Kha   Twohig Daniel   Yan Hongbin  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 30, Iss. 1, 2011-01 ,pp. : 1-11

Taylor & Francis Ltd

Access to resources Recommend Favorite

Antisense oligonucleotide binding to U5 snRNP induces a conformational change that exposes the conserved loop of U5 snRNA

By Ast Gil   Weiner Alan M.  

Nucleic Acids Research, Vol. 25, Iss. 17, 1997-01 ,pp. : 3508-3513

Oxford University Press

Access to resources Recommend Favorite